News
UK patients seek compensation after taking rofecoxib
BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7478.1308-a (Published 02 December 2004) Cite this as: BMJ 2004;329:1308
- Clare Dyer, legal correspondent
- BMJ
British lawyers are gearing up to launch a mass compensation claim in the British courts on behalf of hundreds of patients who had strokes or heart attacks after taking the arthritis drug rofecoxib (Vioxx).
Two law firms, Leigh, Day & Co and Irwin Mitchell, investigated the possibility of suing the manufacturer, Merck, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.